title: Postoperative blood salvage and reinfusion in spinal surgery: blood quality, effectiveness and impact on patient blood parameters.
abstract: Although reinfusion of salvaged shed blood has become popular in major orthopaedic procedures, this blood saving technique is still controversial. In an effort to assess the functional and metabolic status of shed blood erythrocytes and the impact of postoperative shed blood reinfusion on allogenic blood requirements and patient's blood parameters, analyses of perioperative blood samples were performed in 28 consecutive orthopaedic patients undergoing spinal fusion, in which postoperative shed blood was collected and reinfused with the ConstaVac CBC II device. In comparison with a previous series of 31 patients, this procedure reduced allogenic blood requirements by almost 30% (P < 0.05), without any increase in postoperative complications. Postoperative shed blood presented lower haematological values and higher plasma-free haemoglobin (PFHB) levels than preoperative blood, without any disturbance in morphology, median corpuscular fragility (MCF) or erythrocyte adenosine triphosphate (ATP) and diphosphoglycerate (DPG) content. Serum concentrations of enzymes--glutamate-oxalacetate aminotransferase (GOT), glutamate-piruvate aminotransferase (GPT), creatine kinase (CK), lactate dehydrogenase (LDH)--and inflammatory cytokines (IL-1beta, IL-6) were elevated in shed blood. After reinfusion, there was no alteration in coagulation parameters or cytokine levels. Serum levels of some enzymes increased at the end of surgery and remained elevated at postoperative day 2 (CK) or 7 (GOT, LDH), with a higher increase if postoperative autotransfusion was used as a blood saving method. Therefore, caution should be taken when these serum enzyme levels are used for diagnosis. In conclusion, salvaged shed blood in orthopaedic procedures of the spine seems to be an excellent source of red cells which are not significantly damaged, keeping a normal functional and metabolic status, and reduces allogenic blood requirements without significant side effects.
authors.affiliation: Department of Orthopaedic Surgery, Parque San Antonio Hospital, Malaga, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Sebastián
authors.forename: R
authors.initials: R
authors.lastname: Romero
authors.forename: E
authors.initials: E
authors.lastname: Olalla
authors.forename: C
authors.initials: C
authors.lastname: Ferrer
authors.forename: J J
authors.initials: JJ
authors.lastname: García-Vallejo
authors.forename: M
authors.initials: M
authors.lastname: Muñoz
mesh_terms: D001772:Blood Cell Count; D001774:Blood Chemical Analysis; D001780:Blood Coagulation Tests; D016063:Blood Loss, Surgical / Q000503:physiopathology* / Q000517:prevention & control*; D001798:Blood Proteins / Q000276:immunology / Q000378:metabolism; D001804:Blood Transfusion, Autologous / Q000009:adverse effects*; D004912:Erythrocytes / Q000276:immunology / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013123:Spinal Fusion / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D001798:Blood Proteins